Solution Strategies & Research Pathways for Innovative Alternatives to DialysisLearn More
Thank you to our members for their continued supportLearn More
Learn how patients are impacting clinical trials and innovative new therapiesLearn More
To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
KHI's collaborative projects seek input from and bring together members across all areas of the kidney community.
KHI has published many different articles in several of the major, peer-reviewed nephrology journals.
The Kidney Pediatric Accelerator Trial Clearing House (Kidney-PATCH), a Kidney Health Initiative (KHI) project, addresses the major obstacles facing drug development in children with kidney diseases and the rarity of trials for children patients.Learn More
Prabir Roy-Chaudhury, MD, PhD, FASN, served as the ASN Co-Chair for KHI from 2012-2018. Watch this video on ASN TV during Kidney Week 2018 as he spoke on KHI's impact in the nephrology community.Learn More